285
Views
7
CrossRef citations to date
0
Altmetric
Retina/Choroid

Optical Coherence Tomography Angiography of Inflammatory Choroidal Neovascularization Early Response after Anti-VEGF Treatment

, , &
Pages 1556-1562 | Received 22 Dec 2019, Accepted 03 May 2020, Published online: 22 May 2020

References

  • Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116–26. doi:10.1016/j.ophtha.2007.03.008.
  • Giovannini A, Amato GP, Mariotti C, Scassellati-Sforzolini B. OCT imaging of choroidal neovascularisation and its role in the determination of patients’ eligibility for surgery. Br J Ophthalmol. 1999;83:438–42. doi:10.1136/bjo.83.4.438.
  • Perentes Y, Van Tran T, Sickenberg M, Herbort CP. Subretinal neovascular membranes complicating uveitis. Frequency, treatments, and visual outcome. Ocul Immunol Inflamm. 2005;13:219–24. doi:10.1080/09273940490518883.
  • D’Souza P, Ranjan R, Babu U, Kanakath AV, Saravanan VR. Inflammatory choroidal neovascular membrane: long-term visual and anatomical outcomes after intravitreal anti-vascular endothelial growth factor therapy. Retina. 2018;38:1307–15. doi:10.1097/IAE.0000000000001710.
  • Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011;31:871–79. doi:10.1097/IAE.0b013e3182003ca8.
  • Carreno E, Moutray T, Fotis K, Lee RW, Dick AD, Ross AH, Bailey C. Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes. Br J Ophthalmol. 2016;100:1221–26. doi:10.1136/bjophthalmol-2015-307806.
  • Tan ACS, Tan GS, Denniston AK, Keane PA, Ang M, Milea D, Chakravarthy U, Cheung CMG. An overview of the clinical applications of optical coherence tomography angiography. Eye (Lond). 2018;32:262–86. doi:10.1038/eye.2017.181.
  • Moult E, Choi W, Waheed NK, Adhi M, Lee B, Lu CD, Jayaraman V, Potsaid B, Rosenfeld PJ, Duker JS, et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina. 2014;45:496–505. doi:10.3928/23258160-20141118-03.
  • Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20:4710–25. doi:10.1364/OE.20.004710.
  • Spaide RF, Klancnik JM Jr., Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133:45–50. doi:10.1001/jamaophthalmol.2014.3616.
  • Savastano MC, Lumbroso B, Rispoli M. In vivo characterization of retinal vascularization morphology using optical coherence tomography angiography. Retina. 2015;35:2196–203. doi:10.1097/IAE.0000000000000635.
  • Rispoli M, Savastano MC, Lumbroso B. Quantitative vascular density changes in choriocapillaris around CNV after anti-VEGF treatment: dark halo. Ophthalmic Surg Lasers Imaging Retina. 2018;49:918–24. doi:10.3928/23258160-20181203-02.
  • Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET Jr., Neri P, Albini TA, Gupta V, Baynes K, Srivastava SK. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res. 2017;59:178–201. doi:10.1016/j.preteyeres.2017.04.005.
  • Do DV. Detection of new-onset choroidal neovascularization. Curr Opin Ophthalmol. 2013;24:244–47. doi:10.1097/ICU.0b013e32835fd7dd.
  • Spaide RF, Goldberg N, Freund KB. Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina. 2013;33:1315–24. doi:10.1097/IAE.0b013e318286cc77.
  • Amer R, Priel E, Kramer M. Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol. 2015;253:949–57. doi:10.1007/s00417-015-2930-5.
  • Wu K, Zhang X, Su Y, Ji Y, Zuo C, Li M, Wen F. Clinical characteristics of inflammatory choroidal neovascularization in a chinese population. Ocul Immunol Inflamm. 2016;24:261–67. doi:10.3109/09273948.2015.1015741.
  • Lumbroso B, Rispoli M, Savastano MC. Longitudinal optical coherence tomography-angiography study of type 2 naive choroidal neovascularization early response after treatment. Retina. 2015;35:2242–51. doi:10.1097/IAE.0000000000000879.
  • Chen Q, Yu X, Sun Z, Dai H. The application of OCTA in assessment of anti-VEGF therapy for idiopathic choroidal neovascularization. J Ophthalmol. 2016;2016:5608250. doi:10.1155/2016/5608250.
  • Shimada H, Yuzawa M, Hirose T, Nakashizuka H, Hattori T, Kazato Y. Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy. Jpn J Ophthalmol. 2008;52:282–88. doi:10.1007/s10384-008-0566-2.
  • Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9:777–94. doi:10.1111/j.1582-4934.2005.tb00379.x.
  • Lumbroso B, Rispoli M, Savastano MC, Jia Y, Tan O, Huang D. Optical coherence tomography angiography study of choroidal neovascularization early response after treatment. Dev Ophthalmol. 2016;56:77–85. doi:10.1159/000442782.
  • Miere A, Butori P, Cohen SY, Semoun O, Capuano V, Jung C, Souied EH. Vascular remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography. Retina. 2019;39:548–57. doi:10.1097/IAE.0000000000001964.
  • Bruyère E, Miere A, Cohen SY, Martiano D, Sikorav A, Popeanga A, Semoun O, Querques G, Souied EH. Neovascularization secondary to high myopia imaged by optical coherence tomography angiography. Retina. 2017;37:2095–101. doi:10.1097/IAE.0000000000001456.
  • Gulati N, Forooghian F, Lieberman R, Jabs DA. Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2011;95:162–65. doi:10.1136/bjo.2009.177279.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.